Pharmaceutical companies Servier and GeNeuro seem to have made a medical breakthrough. They published preliminary results of a clinical trial of a new drug, GNbAC1, designed to help people with remission-relapsing multiple sclerosis (RRS), Remedium reports.
American scientists have designed an oral drug against HIV, which can be taken once a week. Today patients have to take medications every day. As BBC notes, after successful experiments in pigs, the researchers can initiate clinical tests in humans in the next two years. This is a tablet that slowly releases active substances.
Researchers from the US have discovered a new level of regulation of the connections between neurons and other cells. It turns out that α-ketoglutarate, formed in Krebs cycle that takes place in mitochondria, plays an important role in the transmission of neural signals, Medical Xpress reports.
A sweetener added to sweets, fruit juices, jams, dried and frozen foods, nutritional bars, fruit fillers, instant noodles, rice, white chocolate and other food products can be responsible for the activation of a persistent bacterial infection, The Herald Scotland reports.
For the first time researchers from Duke University have turn the skin cells into a working muscle. This can be a breakthrough in the treatment of diseases such as Duchenne muscular dystrophy. However, the experts note that further research is required, UPI.com reports.
The drug, which was originally intended to be used for the treatment of diabetes but never launched on the market, has found a new life. As The Daily Mail notes, scientists suggest to use it as a remedy for prevention of organ transplant rejection. According to statistics, every sixth patient dies after a heart transplant within a year. And the survivors have the increased risk of infection, weight gain, cancer and diabetes due to the need of using anti-immunity drugs for the rest of their lives.
Scientists from the University of Copenhagen have found out that stem cells can be successfully converted into beta cells of the pancreas that produce insulin. The transplantation of such cells to diabetics will be a real breakthrough in treatment. According to the researchers, about 415 million people suffer from diabetes in the world, NDTV reports.
Scientists from the US have managed to slow down the growth of glioblastoma (the most aggressive form of brain cancer) by using a new device. This device is attached to the shaved part of the patient's head and generates low-intensity electric fields continuously. A network of isolated electrodes directs the fields to a tumor, UPI.com reports.
As Psych Central notes scientists from Germany have found that stuttering is associated with the hyperactivity of the neural network in the right frontal lobe of the brain. According to the experts, this neural network prevents the planning of articulatory movements and their implementation. Due to this, a person stutters.
Scientists of the University of East Anglia have found that leflunomide (a drug from rheumatoid arthritis) may increase the effectiveness of chemotherapy. Leflunomide in combination with a chemotherapeutic drug, selumethinib, has inhibited a tumor growth in mice with melanoma, Zee News reports.